Find investors
← Back to all investors
Aaron M. Segal
ResearchedBoutique Venture Investment Bank / Private Equity

Aaron M. Segal

Partner and Co-Founder · Intuitive Venture Partners LLC

Seed, Early Stage, Growth Stage (Pre-IPO, PIPE, RDO)White Plains, New York (777 Westchester Avenue)
Pitch Aaron

Get their honest, personalized take on your startup.

Sign in to pitch Aaron

At a glance

Title
Partner and Co-Founder
Firm
Intuitive Venture Partners LLC
Firm Type
Boutique Venture Investment Bank / Private Equity
Investment Stage
Seed, Early Stage, Growth Stage (Pre-IPO, PIPE, RDO)
Location
White Plains, New York (777 Westchester Avenue)
Check Size
$2.7M - $80M (based on recent transactions)
Notable Metrics
18 portfolio companies, 1 unicorn, 4 IPOs, 1 acquisition
Firm Founded
2010
Team Size
9 people including 7 partners

Background

Aaron M. Segal is a Partner and Co-Founder at Intuitive Venture Partners LLC, a boutique venture investment bank based in White Plains, New York, which he co-founded in 2010. With over a decade of experience in the finance industry, Aaron has developed a keen eye for identifying disruptive technologies and high-growth potential startups across technology, healthcare, and biotechnology sectors.

Prior to founding Intuitive Venture Partners, Aaron served as Vice President at Spencer Trask Collaborative Innovations LLC from 2001 to 2005, where he played a crucial role in executing complex investment strategies and fostering valuable relationships with industry stakeholders. During his tenure at Spencer Trask, Aaron gained extensive experience in venture capital investment structuring, deal execution, and portfolio company management.

Since establishing Intuitive Venture Partners in 2010, Aaron has positioned the firm as a specialized investment bank that focuses on the structuring, marketing, and execution of private placements of equity and debt securities for both private and public companies. Under his leadership alongside his co-founders, the firm has successfully completed transactions ranging from multi-million dollar SAFE agreements to $80 million PIPE transactions, demonstrating the firm's versatility in capital markets.

Aaron's expertise lies in identifying promising investment opportunities, conducting thorough due diligence, managing portfolio companies, and facilitating complex financial transactions. As a Partner and Co-Founder, he is responsible for overseeing the firm's strategic direction, deal sourcing, and maintaining relationships with entrepreneurs, co-investors, and institutional partners. His approach combines rigorous financial analysis with a deep understanding of emerging technology trends, particularly in areas that intersect technology with healthcare and biotechnology innovation.

Investment Thesis & Focus

Intuitive Venture Partners, under Aaron Segal's leadership, operates as a boutique venture investment bank specializing in growth capital for technology, healthcare, and biotechnology companies. The firm's investment philosophy centers on providing flexible capital solutions to companies at critical inflection points in their growth trajectories.

Investment Approach:

Core Investment Sectors:

Value Proposition: Intuitive Venture Partners differentiates itself by combining investment banking advisory services with direct capital deployment. The firm provides portfolio companies with access to capital markets expertise, strategic advisory services, and connections to co-investors and strategic partners. Aaron and his team emphasize speed of execution and customized transaction structures that align with each company's specific growth objectives and capital needs.

The firm typically co-invests alongside established venture capital firms and strategic investors, positioning itself as a value-added syndicate member that can facilitate complex transactions and provide ongoing capital markets support.

  • Stage Agnostic Within Growth: The firm invests across seed through pre-IPO stages, focusing on companies ready for significant capital deployment
  • Transaction Flexibility: Structures include private placements, PIPEs (Private Investment in Public Equity), RDOs (Registered Direct Offerings), convertible notes, SAFE agreements, and reverse mergers
  • Sector Specialization: Deep focus on technology, healthcare, and biotechnology companies with defensible intellectual property and innovative business models
  • Advanced Technology (AI, communications, defense tech)
  • Biotechnology and Life Sciences
  • Healthcare Technology
  • Environmental and Clean Technology
  • Nuclear Energy and Advanced Energy Solutions
  • Robotics and Automation

Notable Investments

  • Pieris Pharmaceuticals - Biotechnology company; IPO syndicate member with $13.6M investment
  • Uniphore - AI-powered customer service platform; achieved unicorn status ($1B+ valuation)
  • Serve Robotics - Autonomous sidewalk delivery robots; public company (Nasdaq)
  • Deep Fission, Inc. - Nuclear energy technology; $80M PIPE (Feb 2026) and $30M private placement & reverse merger (Sep 2025)
  • Deep Isolation, Inc. - Nuclear waste storage solutions; $33M private placement & reverse merger (Jul 2025)
  • Eridan Communications, Inc. - RF communications technology; $12M (Jan 2025) and $12.7M (Aug 2024) preferred stock placements
  • PeerNova, Inc. - Enterprise blockchain solutions; $40M convertible note (Dec 2024)
  • Anduril Holdings SPV - Defense technology; $4M private placement (Dec 2024)
  • r4 Technologies, Inc. - Technology company; $30M convertible note (Nov 2024)
  • Mentium Technologies, Inc. - Technology startup; $2.7M SAFE (Jun 2024)
  • Titan Environmental Solutions - Environmental technology; $4.8M preferred stock & warrants (May 2024)
  • 1 unicorn exit (Uniphore)
  • 4 IPOs including Pieris Pharmaceuticals and Serve Robotics
  • 1 acquisition
  • Total of 18 portfolio companies

Unlock the full research

Get how to approach them, recent activity, sources, contact links — plus pitch their AI twin for a candid read on your raise.

One-time. Stays unlocked for you.